Evidence map›Paper›PMID 34297098›Full record

ArticleJournal of AOAC International2021

LC-ESI-MS/MS Simultaneous Analysis Method Coupled with Cation-Exchange Solid-Phase Extraction for Determination of Pyrrolizidine Alkaloids on Five Kinds of Herbal Medicines.

Se Hee Jeong, Eun Young Choi, Jonghwan Kim, Chulhyun Lee, Juhye Kang, Sooyeul Cho, Kyung Yuk Ko

Open access · hybridAbstract read
In one paragraph

Article in Journal of AOAC International, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Identification of Pyrrolizidine Alkaloids inJournal of analytical methods in chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Se Hee JeongNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0002-4051-5688
Eun Young ChoiNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0003-1109-2986
Jonghwan KimNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0002-4988-5781
Chulhyun LeeNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0002-6242-3776
Juhye KangNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0002-1268-5655
Sooyeul ChoNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0001-6513-5879
Kyung Yuk KoNational Institute of Food and Drug Safety Evaluation, Herbal Medicine Research Division, Osong-eup, Cheongju-si, Chungbuk 28159, Republic of Korea.ORCID 0000-0001-9139-7354
National Institute of Food and Drug Safety Evaluation · KR

Funding

LC-MS/MS analysisMinistry of Food and Drug Safety 19171MFDS193
6 · The paper itself

Abstract

backgroundPyrrolizidine alkaloids (PAs) are naturally occurring plant toxins associated with potential hepatic and carcinogenic diseases in humans and animals. The concern over PAs has increased as the consumption of herbal medicines has increased.

objectiveThis study aimed to develop and validate a sensitive analytical method to determine 28 PAs in five herbal medicines using liquid chromatography (LC)-electrospray ionization (ESI)-tandem mass spectrometry (MS/MS). Additionally, this study identified and quantified the amount of PAs in 10 samples of each herbal medicine.

methodsThe pretreatment in the proposed LC-MS/MS analysis comprised solvent extraction using 0.05M H2SO4 in 50% methanol and clean-up step using an mixed-mode cationic exchange (MCX)-solid-phase extraction (SPE) cartridge. The PA contents in herbal medicines were measured by using the developed method.

resultsThe proposed method had recoveries ranging from 72.5-123.7% for the Atractylodis Rhizoma Alba, 70.6-151.7% for Alba Chrysanthmi Flos, 80.6-130.9% for Leonuri Herba, 70.3-122.9% for Gastrodiae Rhizoma, and 67.1-106.9% for Glycyrrhizae Radix. Even though a few samples showed recoveries in unsatisfactory values, the proposed method indicated entirely sufficient recoveries and precision in most samples. In monitoring results, only Leonuri Herba contained two PAs, which indicated Retrorsine (4/10) of 84.7-120.9 μg/kg and Senkirkine (10/10) of 60.9-170.7 μg/kg.

conclusionThe results obtained from this study demonstrate that the proposed method is fit for purpose to determine 28 PAs in herbal medicines. Therefore it could serve as a regulatory method capable of being used for controlling the risks of PAs in certain medicinal plants and dietary supplements. HIGHLIGHTS: An LC-MS/MS method for the determination of 28 pyrrolizidine alkaloids in herbal medicines was developed and validated through this study. The proposed method is considered as an useful method for monitoring pyroolizidine alkaloids in herbal medicines.

Indexed as

Plants, MedicinalPyrrolizidine AlkaloidsCationsChromatography, High Pressure LiquidChromatography, LiquidHumansSolid Phase ExtractionSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryCationsPyrrolizidine Alkaloids

Identifiers

PMID34297098
PMCPMC8665765
OpenAlexW3185569946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.